{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:26:08Z","timestamp":1791087968384,"version":"4.1.0"},"reference-count":97,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiology"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:p>Hyperlipidemia and its treatment are currently recognized as important modulators of cardiovascular mortality in the presence of disordered glucose control. On the other hand, the effects of hyperglycemia and its treatment on hyperlipidemia are not widely appreciated. Hyperglycemia is commonly associated with an increase in intestinal lipoproteins and a reduction in high-density lipoprotein (HDL). This could be a consequence of hyperglycemia-induced glycation of lipoproteins, which reduces the uptake and catabolism of the lipoproteins via the classical low-density lipoprotein (LDL) receptor. A high dietary carbohydrate load increases the glycation of intestinal lipoproteins, prolongs their circulation, and increases their plasma concentration. Hyperglycemia also leads to inhibition of lipoprotein lipase, further aggravating hyperlipidemia. Circulating advanced glycation end-products (AGEs) also bind lipoproteins and delay their clearance, a mechanism that has particularly been implicated in the dyslipidemia of diabetic nephropathy. As uptake via scavenger receptors is not inhibited, glycation increases the proportion of lipoproteins that are taken up via inflammatory cells and decreases the proportion taken up by hepatocytes via classical LDL receptors. This promotes the formation of atheromatous plaques and stimulates inflammation. Hyperglycemia increases the formation of oxidized LDL and glycated LDL, which are important modulators of atherosclerosis and cardiovascular death. The risk of cardiovascular death is increased by even short-term derangement of blood sugar control, owing perhaps to the glycation of lipoproteins and other critical proteins. Glycated LDL could prove very useful in measuring the effect of hyperglycemia on cardiovascular disease, its risk factors, and its complications. Comparing different glucose-lowering and lipid-lowering drugs in respect to their influence on glycated LDL could increase knowledge of the mechanism by which they alter cardiovascular risk.<\/jats:p>","DOI":"10.1177\/000331970505600411","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T16:26:23Z","timestamp":1143822383000},"page":"431-438","source":"Crossref","is-referenced-by-count":59,"title":["Hyperglycemia, Lipoprotein Glycation, and Vascular Disease"],"prefix":"10.1177","volume":"56","author":[{"given":"Arvindan","family":"Veiraiah","sequence":"first","affiliation":[{"name":"Llandough Hospital, Penarth, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2005,7]]},"reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.1177\/1358836X9900400203"},{"issue":"1","key":"e_1_2_1_2_1","first-page":"93","article-title":"Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: The Paris Prospective Study","volume":"17","author":"Fontbonne A","year":"1991","unstructured":"Fontbonne A, Eschwege E: Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: The Paris Prospective Study. Diabetes Metab 17(1 Pt 2):93-95, 1991.","journal-title":"Diabetes Metab"},{"key":"e_1_2_1_3_1","volume-title":"CARDS study halted due to benefit of atorvastatin in patients with type 2 diabetes","author":"Jeffrey S","year":"2003","unstructured":"Jeffrey S: CARDS study halted due to benefit of atorvastatin in patients with type 2 diabetes. From www.theheart.org [HeartWire > News]; Jun 18, 2003. Accessed at http:\/\/www.theheart.org\/viewArticle.do?primaryKey=347771 on July 16, 2004."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-8-200404200-00013"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.002"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01231.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2713"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(01)00139-8"},{"key":"e_1_2_1_9_1","first-page":"11i","article-title":"The National Cholesterol Guidelines in 2001, Adult Treatment Panel (ATP) III. Approach to lipoprotein management in 2001 National Cholesterol Guidelines","volume":"90","author":"Grundy SM","year":"2002","unstructured":"Grundy SM, and the National Cholesterol Education Program (NCEP): The National Cholesterol Guidelines in 2001, Adult Treatment Panel (ATP) III. Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol 90:11i-21i, 2002.","journal-title":"Am J Cardiol"},{"key":"e_1_2_1_10_1","first-page":"22","article-title":"Prevalence of lipid abnormalities in Sri Lankan patients with non-insulin dependent diabetes mellitus","volume":"39","author":"Siribaddana S","year":"1994","unstructured":"Siribaddana S, Perera N, Perera S, et al: Prevalence of lipid abnormalities in Sri Lankan patients with non-insulin dependent diabetes mellitus. Ceylon Med J 39:22-25, 1994.","journal-title":"Ceylon Med J"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456329102800407"},{"key":"e_1_2_1_12_1","first-page":"1057","article-title":"[Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population","volume":"124","author":"Kohler C","year":"1999","unstructured":"Kohler C, Temelkova-Kurktschiev T, Schaper F, et al: [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes.] Dtsch Med Wochenschr 124:1057-1061, 1999.","journal-title":"Data from the RIAD study using new diagnostic criteria for diabetes.] Dtsch Med Wochenschr"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.10.1066"},{"key":"e_1_2_1_14_1","first-page":"309","article-title":"The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study","volume":"173","author":"Ford ES","year":"2004","unstructured":"Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173:309-314, 2004.","journal-title":"Atherosclerosis"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.5.1195"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.781"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600887"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90129-8"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90648-X"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92184-X"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.8.6.737"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815753"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2002.00997.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1997.tb04342.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.11.6"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00700-0"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00484-6"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(95)05647-5"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.152"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.6.989"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.12.1585"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-4-527"},{"issue":"2","key":"e_1_2_1_33_1","first-page":"B65","article-title":"Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications","volume":"22","author":"Friedman EA","year":"1999","unstructured":"Friedman EA: Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22(suppl 2):B65-B71, 1999.","journal-title":"Diabetes Care"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2000.0204"},{"key":"e_1_2_1_35_1","first-page":"3243","article-title":"Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: Relation to nonenzymatic glycosylation and oxidative modification","volume":"86","author":"Sanchez-Quesada JL","year":"2001","unstructured":"Sanchez-Quesada JL, Perez A, Caixas A, et al: Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: Relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab 86:3243-3249, 2001.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2003.07.001"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.75.1.11"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00262-5"},{"key":"e_1_2_1_39_1","first-page":"25","article-title":"Minimally oxidized LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy","volume":"22","author":"Picard S","year":"1996","unstructured":"Picard S, Talussot C, Serusclat A, et al: Minimally oxidized LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy. Diabetes Metab 22:25-30, 1996.","journal-title":"Diabetes Metab"},{"key":"e_1_2_1_40_1","first-page":"349","article-title":"Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis","volume":"15","author":"Fornasieri A","year":"2002","unstructured":"Fornasieri A, Perugini C, Seccia M, et al: Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis. J Nephrol 15:349-357, 2002.","journal-title":"J Nephrol"},{"key":"e_1_2_1_41_1","first-page":"486","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592, 2001","volume":"4","author":"Brown BG","year":"2002","unstructured":"Brown BG, Zhao XQ, Chait A, et al: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592, 2001. Summary for patients in: Curr Cardiol Rep 4:486, 2002.","journal-title":"Summary for patients in: Curr Cardiol Rep"},{"key":"e_1_2_1_42_1","first-page":"1134","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357:89-95, 2001","volume":"357","author":"de Gaetano G","year":"2001","unstructured":"de Gaetano G, and the Collaborative Group of the Primary Prevention Project: Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357:89-95, 2001. Erratum in: Lancet 357:1134, 2001.","journal-title":"Erratum in: Lancet"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(96)00106-7"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00005-7"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.6.1331"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.1.8175"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.7.1140"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2002.00212.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.5.1240"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.31.746"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.9.1090"},{"key":"e_1_2_1_52_1","first-page":"1035","article-title":"Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]","volume":"44","author":"Galle J","year":"1998","unstructured":"Galle J, Winner B, Conzelmann E, et al: Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]. Cell Mol Biol (Noisy-le-grand) 44:1035-1045, 1998.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1002089"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7643"},{"key":"e_1_2_1_55_1","first-page":"45","article-title":"Radioimmunoassay of glycated serum protein using monoclonal antibody to glucitollysine and coomassie-brilliant-blue-coated polystyrene beads","volume":"11","author":"Yamamoto Y","year":"1989","unstructured":"Yamamoto Y, Tahara Y, Cha T, et al: Radioimmunoassay of glycated serum protein using monoclonal antibody to glucitollysine and coomassie-brilliant-blue-coated polystyrene beads. Diabetes Res 11:45-49, 1989.","journal-title":"Diabetes Res"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9441"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300435-JLR200"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404637"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00275-0"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.35177"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.9.1093"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124718.99562.91"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-821023"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.4.880"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.04.001"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.20.2626"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0956-5663(02)00168-9"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1039\/b008725o"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(02)00188-9"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)32407-X"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6572"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/00033197040550i601"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.4.369"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01112.x"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00422-3"},{"key":"e_1_2_1_76_1","first-page":"317","article-title":"[Prognostic significance of transient hyperglycemia in acute phase of ischemic stroke.]","volume":"32","author":"Slowik A","year":"1998","unstructured":"Slowik A, Zwolinska G, Tomik B, et al: [Prognostic significance of transient hyperglycemia in acute phase of ischemic stroke.] Neurol Neurochir Pol 32:317-329, 1998.","journal-title":"Neurol Neurochir Pol"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.67.61"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1345-3"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(02)04997-4"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16937-7"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/76.1.281S"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/75.3.492"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.8.927"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2002000800004"},{"key":"e_1_2_1_85_1","first-page":"129","article-title":"Improvement of glycaemic control in type 2 diabetes: Favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin","volume":"61","author":"Becker A","year":"2003","unstructured":"Becker A, van der Does FE, van Hinsbergh VW, et al: Improvement of glycaemic control in type 2 diabetes: Favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin. Neth J Med 61:129-136, 2003.","journal-title":"Neth J Med"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16949-3"},{"key":"e_1_2_1_87_1","first-page":"S3","article-title":"Glycemic index in relation to coronary disease","volume":"13","author":"Brand-Miller JC","year":"2004","unstructured":"Brand-Miller JC: Glycemic index in relation to coronary disease. Asia Pac J Clin Nutr 13(suppl):S3, 2004.","journal-title":"Asia Pac J Clin Nutr"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7277.15"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.201"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_1_91_2","first-page":"602","volume":"354","year":"1999","unstructured":"Erratum in: Lancet 354:602, 1999.","journal-title":"Lancet"},{"key":"e_1_2_1_92_1","first-page":"830","article-title":"[Protection from sunlight, particularly for children.]","volume":"144","author":"van Praag MC","year":"2000","unstructured":"van Praag MC, Pavel S, Menke HE, et al: [Protection from sunlight, particularly for children.] Ned Tijdschr Geneeskd 144:830-834, 2000.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_1_93_1","first-page":"173","article-title":"[Serum fructosamine in healthy and diabetic children and adolescents.]","volume":"203","author":"Schlebusch H","year":"1991","unstructured":"Schlebusch H, Liappis N, Sorger M, et al: [Serum fructosamine in healthy and diabetic children and adolescents.] Klin Padiatr 203:173-177, 1991.","journal-title":"Klin Padiatr"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106949"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90020-3"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0030fje"}],"container-title":["Angiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000331970505600411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000331970505600411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:13:36Z","timestamp":1777371216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/000331970505600411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1177\/000331970505600411"],"URL":"https:\/\/doi.org\/10.1177\/000331970505600411","relation":{},"ISSN":["0003-3197","1940-1574"],"issn-type":[{"value":"0003-3197","type":"print"},{"value":"1940-1574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}